Chronic Diarrhea in Travelers Authors
Tropical, Travel and Emerging Infections (L Chen, Section Editor)
First Online: 27 March 2013 DOI:
Cite this article as: Connor, B.A. Curr Infect Dis Rep (2013) 15: 203. doi:10.1007/s11908-013-0328-2 Abstract
As a rule, travelers’ diarrhea is a self-limited bacterial infection that affects approximately 40 % of travelers to developing countries. Health-care professionals who see returning travelers have noted that some travelers afflicted with diarrhea do not recover completely but, instead, develop chronic diarrhea or a persistent change in gastrointestinal function. Concurrent with this observation has been the recognition that in many patients with long-standing irritable bowel syndrome, an episode of traveler’s diarrhea or gastroenteritis preceded the onset of symptoms. Before a diagnosis of postinfectious irritable bowel syndrome is considered, other diagnostic considerations must be excluded. This review will examine an approach to the patient with chronic diarrhea posttravel.
Keywords Travelers’ diarrhea Chronic diarrhea Persistent diarrhea Bacterial diarrhea Clostridium difficile Enteric parasitic infection Celiac disease Inflammatory bowel disease Brainerd diarrhea Postinfectious irritable bowel syndrome References Papers of particular interest, published recently, have been highlighted as: • Of importance
Connor BA. Travelers' Diarrhea. Centers for Disease Control and Prevention: Health Information for International Travel 2012: Yellow Book. 2012 Oxford University Press 56–60.
Shlim DR, Hoge CW, Rajah R, et al. Persistent High Risk of Diarrhea among Foreigners in Nepal during the First 2 Years of Residence. Clin Infect Dis. 1999;29(3):613–9.
Hoge CW, Shlim DR, Echevarria P. Epidemiology of diarrhea among expatriate residents living in a highly endemic environment. JAMA. 1996;275:533–8.
Taylor DN, Houston R, Shlim DR. Etiology of diarrhea among travelers and foreign residents in Nepal. JAMA. 1988;260:1245–8.
Ortega YR, Adam R. Giardia: overview and update. Clin Infect Dis. 1997;25:545–50.
Addis DG, Mathews HM, Stewart JM. Evaluation of a commercially available enzyme-linked immunosorbent assay for Giardia lamblia testing in stool. J Clin Microbiol. 1991;29:1137.
Goka AK, Rolston DD, Mathan VI. The relative merits of faecal and duodenal juice microscopy in the diagnosis of giardiasis. Trans R Soc Trop Med Hyg. 1990;84:66.
Hoge CW, Shlim DR, Rajah R, et al. Epidemiology of diarrhoeal illness associated with coccidian-like organism among travellers and foreign residents in Nepal. Lancet. 1993;341(8854):1175–9.
Connor BA, Shlim DR, Scholes JV, et al. Pathologic changes in the small bowel in nine patients with diarrhea associated with a coccidian-like body. Ann Int Med. 1993;119:377–82.
Hoge CW, Shlim DR, Ghimire M, et al. Placebo-controlled trial of co-trimoxazole for Cyclospora infections among travelers and foreign residents in Nepal. Lancet. 1995;345:691–3.
Bhan MK, Raj P, Levine MM. Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India. J Infect Dis. 1989;159:1061–4.
Gascôn J, Vargas M, Quinté L. Enteroaggregative Escherichia coli strains as a cause of travelers’ diarrhea: a case control study. J Infect Dis. 1998;177:1409–12.
Golledge CL, Riley TV. Clostridium difficile-associated diarrhea after doxycycline malaria prophylaxis. Lancet. 1995;345:1377–8.
Farthing MJG. Tropical malabsorption and tropical diarrhea. In: Feldman M, Scharschmidt BF, Sleisenger MH, editors. Sleisenger & Fordtran’s gastrointestinal and liver disease. 6th ed. Philadelphia: WB Saunders; 1998. p. 1574–84.
Klipstein FA. Tropical sprue in travelers and expatriates living abroad. Gastroenterology. 1981;80:590–600.
Cook GC. Aetiology and pathogenesis of postinfective tropical malabsorption (tropical sprue). Lancet. 1984;i:721–3.
Osterholm MT, MacDonald KL, White KE. An outbreak of a newly recognized chronic diarrhea syndrome associated with raw milk consumption. JAMA. 1986;256:484–90.
Mintz ED, Weber JT, Guris D. An outbreak of Brainerd diarrhea among travelers to the Galapagos Islands. J Infect Dis. 1998;177:1041.
• Hansen R, Thomson EM, El-Omar GL, et al. The role of infection in the aetiology of inflammatory bowel disease. J Gastroenterol. 2010;45:266–76.
This review highlights the current state of the art with respect to infection as a viable candidate for pathogenesis of inflammatory bowel disease.
• Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357(17):1731–43.
An excellent review of celiac disease by one of the foremost researchers and clinicians involved in the care of patients with tlhis disorder, highlighting its epidemiology and possible contribution as a cause of previously undiagnosed gastrointestinal symptoms.
Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163(3):286–92.
Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137(1):88–93.
Hadithi M, von Blomberg BM, Crusius JB, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med. 2007;147:294.
• Carroccio A, Mansueto P, Iacono G, et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol. 2012;107:1898.
A double-blind placebo-controlled challenge study of a newly described clinical entity, non-celiac wheat sensitivity, which is being increasingly diagnosed and should be considered in this population as well.
Sanders DS, Aziz I. Non-celiac wheat sensitivity: separating the wheat from the chat! Am J Gastroenterol. 2012;107:1908.
Biesiekierski JR, Newnham ED, Irving PM, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol. 2011;106:508.
Harries AD, Myers B, Cook GC. Inflammatory bowel disease: a common cause of bloody diarrhea in visitors to the tropics. BMJ. 1985;291:1686–7.
Hotte NSC, Salim SY, Tso RH, et al. Patients with Inflammatory Bowel Disease Exhibit Dysregulated Responses to Microbial DNA. PLos ONE 7 (5): e37932.
Case Records of the Massachusetts General Hospital. Case 29–1992. N Engl J Med. 1992;91:182–91.
Taylor DN, Connor BA, Shlim DR. Chronic Diarrhea in the Returned Traveler. Med Clin North Am. 1999;83(4):1033–52.
Connor BA. Sequelae of traveler's diarrhea: focus on postinfectious irritable bowel syndrome. Clin Infect Dis. 2005;41 Suppl 8:S577–86.
Stewart GT. Post-Dysenteric Colitis BMJ. 1950; 405–409.
Spiller R. Irritable Bowel Syndrome. Br Med Bull. 2005;72(1):15–29.
Borgaonkar MR, Ford DC, Marshall JK, et al. The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection. Dig Dis Sci. 2006;51:1026–32.
McKendrick MW, Read NW. Irritable bowel syndrome–post salmonella infection. J Infect. 1994;29:1–3.
• Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136:1979–88.
An excellent overview of the current state of knowledge of post-infectious irritable bowel syndrome with respect to its clinical presentation and pathogenesis.
Okhuysen PC, Jiang ZD, Carlin L, et al. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol. 2004;99:1774–8.
Ilnyckyj A, Balachandra B, Elliott L, et al. Post-traveler's diarrhea irritable bowel syndrome: a prospective study. Am J Gastroenterol. 2003;98:596–9.
Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ. 1999;318:565–6.
Parry SD, Stansfield R, Jelley D, et al. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case–control study. Am J Gastroenterol. 2003;98:1970–5.
• Trivedi KH, Schlett CD, Tribble DR, et al. The impact of post-infectious functional gastrointestinal disorders and symptoms on the health-related quality of life of US military personnel returning from deployment to the Middle East. Dig Dis Sci. 2011;56(12):3602–9.
One of the first studies looking at the impact of post-infectious functional disorders including irritable bowel syndrome in a specific group of travelers, i.e. military personnel, and the contribution of antecedent travelers' diarrhea in this population.
Stermer E, Lubezky A, Potasman I, et al. Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis. 2006;43:898–901.
Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1ß in recently acquired post-infectious irritable bowel syndrome. Gut. 2003;52:523–6.
Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804–11.
Dunlop S, Jenkins D, Neal K, Spiller R. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125:1651–9.
Gwee KA, Graham JC, McKendrick MW, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet. 1996;347:150–3.
Gwee K-A, Leong Y-L, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400–6.
Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:535–44.
Parry SD, Barton JR, Welfare MR. Factors associated with the development of post-infectious functional gastrointestinal diseases: does smoking play a role? Eur J Gastroenterol Hepatol. 2005;17:1071–5.
Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut. 2002;51:410–3.
van der Veek PPJ, van den Berg M, de Kroon YE, et al. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am J Gastroenterol. 2005;100:2510–6.
Gonsalkorale WM, Perrey C, Pravica V, et al. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut. 2003;52:91–3.
Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol. 2009;15:3591–6.
Pimentel M, Chatterjee S, Chang C, et al. A new rat model links two contemporary theories in irritable bowel syndrome. Dig Dis Sci. 2008;53:982–9.
Jee SR, Morales W, Low K, et al. ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS. World J Gastroenterol. 2010;16:3680–6.
Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut. 2004;53:1096–101.
Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology. 2003;124:1662–71.
Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol. 2007;42 Suppl 17:41–7.
Lin HC. Small intestinal bacterial overgrowth: a framework for understanding rritable bowel syndrome. JAMA. 2004;292:852–8.
Pimentel M, Park S, Kong Y, et al. Rifaximin, a non-absorbable antibiotic improves the symptoms of irritable bowel syndrome: A double-blind randomized controlled study. Am J Gastroenterol. 2005;100:S321–45.
• Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22–32.
This study is significant because it suggests that symptomatic relief is possible in patients with PI-IBS by eradicating small intestinal bacterial overgrowth, a purported consequence of disordered motility related to traveler's diarrhea.
Pimentel M, Morales W, Lezcano S, et al. Low-Dose Nocturnal Tegaserod or Erythromycin Delays Symptom Recurrence After Treatment of Irritable Bowel Syndrrome Based on Presumed Bacterial Overgrowth. Gastroenterol Hepatol. 2009;5(6):435–42.
© Springer Science+Business Media New York 2013